Cita APA (7a ed.)

Opalińska, M., Sowa-Staszczak, A., Grochowska, A., Olearska, H., & Hubalewska-Dydejczyk, A. (2021). Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A.

Cita Chicago Style (17a ed.)

Opalińska, Marta, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, y Alicja Hubalewska-Dydejczyk. Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A, 2021.

Cita MLA (8a ed.)

Opalińska, Marta, et al. Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A, 2021.